Updates to BC-CfE HIV Drug Treatment and Prevention Programs

  • Formulary Addition: Dolutegravir-lamivudine (Dovato®)
  • Resumption of routine HIV plasma viral load testing
  • Updates to BC-CfE Guidance Documents
Scroll to Top